FINWIRES · TerminalLIVE
FINWIRES

Neuren Pharmaceuticals' Nasdaq-Listed Partner Reports 20% Increase in Q1 Net Sales of Rett Syndrome Drug; Shares Up 3%

By

Neuren Pharmaceuticals' (ASX:NEU) Nasdaq-listed partner, Acadia Pharmaceuticals, reported a 20% increase in first-quarter net sales of Rett syndrome drug Daybue to $101 million from $85 million in the previous corresponding period, according to a Thursday filing with the Australian bourse.

Neuren earned royalty income of $10.4 million in the first quarter, up 23% on the same time last year, the filing said.

Anticipated full-year royalties remain between $50 million and $54 million.

Additionally, Acadia maintained its full-year guidance for Daybue net sales of $460 million to $490 million, per the filing.

Neuren Pharmaceuticals shares rose 3% in midday trade on Thursday.

Related Articles

Asia

Ley Choon Unit Bags SG$36 Million Contracts; Shares Up 3%

Ley Choon's (SGX:Q0X) subsidiary, Ley Choon Constructions and Engineering, secured underground utilities services contracts worth SG$35.6 million, according to a Tuesday filing with the Singapore Exchange.Shares of the underground infrastructure services company were up nearly 3% in Wednesday trading.The contracts are expected to conclude within 24 to 36 months.

SGX:Q0X
Asia

Goldwind Science & Technology to Provide Wind Turbine Services in Morocco for $29 Million; Hong Kong Shares Down 3%

Goldwind Science & Technology (SHE:002202, HKG:2208) agreed to provide long-term operation and maintenance services for wind turbines in Morocco for a total guarantee amount of up to $29.4 million, according to a Shenzhen bourse filing on Wednesday.The deal was signed with Energie Eolienne du Maroc through a subsidiary, Goldwind Morocco (SARL).The Chinese wind power company's Hong Kong shares dropped 3%, while Shenzhen shares rose less than 3% during morning trade.

HKG:2208SHE:002202
Asia

AusQuest Says Reverse Circulation Drilling at Peru Porphyry Copper-Gold Project Defines Continuous Mineralized Corridor

AusQuest (ASX:AQD) said reverse circulation drilling continues to define a continuous mineralized corridor extending more than 1,500 meters in length at the Cangallo porphyry copper-gold project in Peru, according to a Wednesday Australian bourse filing.Drilling encountered intercepts of 269 meters at 0.3% grade of copper and 0.1 grams per tonne (g/t) grade of gold from 160 meters, as well as 214 meters at 0.3% grade of copper and 0.1 g/t grade of gold from 124 meters.The company said that permitting of the stage four drill pads was prioritized to enable further drilling in the highly prospective southern portion of the prospect.

ASX:AQD